🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
AICOVI (Adaptive Immune Response to COVID-19 Vaccination) is a prospective ...
Status
Unknown
Location
University Medicine Greifswald
Start Date
2021-01-06
Trial ID
NCT04826770
COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus ...
Status
Unknown
Location
Institute of Liver & Biliary Sciences
Start Date
2021-03-19
Trial ID
NCT04794946
Treatments Being Tested
A phase 2/3 study to determine the efficacy, safety and immunogenicity of t...
Status
Completed
Location
University Hospital Southampton NHS Foundation Trust
Start Date
2020-05-28
Trial ID
NCT04400838
Treatments Being Tested
Rationale: Early in the covid-19 pandemic, it was unclear whether and how i...
Status
Completed
Location
National Institute for Research in Tuberculosis
Start Date
2021-05-07
Trial ID
NCT05049187
This is a phase III, randomized, observer-blind, active-controlled, paralle...
Status
Completed
Location
Trial site
Start Date
2022-10-01
Trial ID
NCT05572879
Treatments Being Tested
A total sample size of 875 healthy volunteers ages ≥18 years will be recrui...
Status
Completed
Location
All India Institute of Medical Sciences
Start Date
2022-02-26
Trial ID
NCT05567471
Treatments Being Tested
SpiN-Tec MCTI UFMG will be used as a vaccine booster against COVID-19 and w...
Status
Completed
Location
Faculdade de Medicina da UFMG - Unidade de Pesquisa Clínica em Vacinas (UPqVac)
Start Date
2022-11-23
Trial ID
NCT07134725
A phase III, randomized, observer-blind, active-controlled, parallel-group,...
Status
Completed
Location
Trial site
Start Date
2022-07-11
Trial ID
NCT05603052
Treatments Being Tested
A multicenter, randomized, double-blind, active comparator, non-inferiority...
Status
Unknown
Location
Multiple Locations
Start Date
2023-01
Trial ID
NCT05542693
The main goals of this study are to assess the immune response and safety o...
Status
Active Not Recruiting
Location
Royal Inland Hospital
Start Date
2021-05-20
Trial ID
NCT04894435